pharmaceutical industry Articles
-
Adaptive strategies in the Indian pharmaceutical industry
Trade liberalisation and proposed changes in the IPR has ushered in new dynamics in the Indian Pharmaceutical industry. Referring to theoretical debate on industrial organisational policies, the pharmaceutical industry is moving towards consolidation and augmentation, thus towards a "new industrial order". The pharmaceutical industry's adaptation to change, as shown in this article, is ...
-
Strategic innovation management of change in the pharmaceutical industry
The pharmaceutical industry is currently preparing for a transition in many countries that gives rise to many unanswered questions regarding innovation strategy and ultimately may threaten the survival of companies in the industry. The cause of this transition is the GATT/WTO agreement that these countries signed in 1995. This agreement has broad implications for intellectual property rights, and ...
-
WinLims for the pharmaceutical industry
The production of pharmaceuticals is highly regulated by the FDA, MCA, and other regulatory organisations around the world. Auditing of pharmaceutical companies is carried out on a regular basis to ensure that all areas of the business are adhering to the approved quality procedures. The laboratories and any LIMS in use are subjected to this scrutiny. Hence it is crucial for WinLIMS to provide ...
-
Sustainable use of biodiversity by the pharmaceutical industry?
This paper discusses a key aspect of a sustainable pharmaceutical use of biodiversity: the increased demand of the pharmaceutical industry for biogenetic resources does not result in an increase of the market value of biodiversity. The increasing interest in biogenetic resources by the pharmaceutical industry since the late 1980s has led, among other things, to contracts between large ...
-
The changing role of technology suppliers in the pharmaceutical industry: the case of drug delivery companies
In this paper, preliminary results of a research project on strategies of drug delivery companies (DDC) are presented to discuss the changing role of technology suppliers in the pharmaceutical industry. Changes in the pharmaceutical industry are presented briefly and related to developments in the drug delivery industry. The early observations are contrasted with existing views from the ...
-
Knowledge-based industry after market liberalisation: the case of the local pharmaceutical industry in Central and Eastern Europe
Research of the strategic aspects of the generic pharmaceutical industry in Central and Eastern Europe (CEE) suggests that generic pharmaceutical companies have neglected technological innovation capability, market orientation and performance and have underestimated the process of globalisation. This has resulted in deteriorated performance and lost competitiveness. A recommended approach to ...
-
Challenges to improving access to essential drugs: perspectives from across the divide
This paper examines the principal challenges to improving the accessibility to healthcare and medicines in developing countries. The analysis draws on current literature to provide an overview of the factors that have led to the disparity in healthcare access; the problems of developing nations in overcoming such impediments and the challenges faced by the providers of medicines, namely that of ...
-
Capability portfolio for the initial phase of internationalisation of emerging economy firms: a study in the Indian pharmaceutical industry
This paper analyses the internationalisation experiences of seven firms in the Indian pharmaceutical industry and identifies the portfolio of capabilities required in the initial phase of internationalisation. It traces the priorities, simultaneity and sequence in the capability development process and identifies the differences between early and late internationalisers. It notes that studies so ...
-
Case Study - Pharmaceutical Industry
A biotechnology company in New England purchased an integrated pretreatment RO/EDI system for a cGMP-validated application. Since the system integrates some of the latest technologies of membranes, UV and EDI they required someone with the expertise and experience to commission the system, train personnel and be available for consultation. Applied Water Solutions met with the owner, contractor ...
-
The global pharmaceutical industry: changing competitive landscape
The paper analyses the changing landscape of the global pharmaceutical industry. The study analyses the forces driving the change and the enabling factors that facilitate the response of various firms in the pharmaceutical industry, leading to consolidation and restructuring of the industry. A number of new technology platforms are emerging that are facilitating this change process. In the ...
-
Electronic Data in Pharmaceutical Manufacturing: Data Integrity (Series Part 1 of 6)
Data Integrity - Data Storage & Retrieval Data integrity means data that is accurate, complete and repeatable, which in turn ensures the product’s quality and public safety. Compliance is the goal of improving process control, product quality and Regulator confidence while reducing product defects and costs. Both of these concepts work hand-in-hand and apply to multiple areas of the ...
-
New trends in biotechnology networking
The paper explores two emerging trends in biotechnology networking: the role of strategic partnering activity in the formation of knowledge-based networked oligopolies particularly in the pharmaceutical industry and the extension of partnering activity in biotechnology from advanced industrial to Third World countries. Both trends, it argues, bear further examination by both researchers seeking ...
-
The biotechnology revolution: implications for the pharmaceutical industry
Until recently, many of the larger pharmaceutical companies were exclusively responsible for the discovery of novel treatments through the efforts of their own in-house research. However, the arrival of biotechnology was to change these traditional patterns of innovation. Today, pharmaceutical manufacturers no longer view themselves as the sole innovators in the industry. Rather, they are ...
-
Global pharmaceutical industry: intellectual wealth and asset protection
This is a commentary on the recent trends in the protection of intellectual assets in the Global Pharmaceutical Industry. Patenting inventions, enforcing acquired rights, evolving newer ways of sharing knowledge for effective cooperative working through diverse licensing arrangements between organisations are the keys to success in this fiercely competitive industry.Keywords: intellectual assets, ...
-
Environmental Profile of the Pharmaceutical Industry
Introduction The EPA's Office of Compliance has developed a series of profiles or notebooks containing information on selected major industries. These notebooks, which focus on key indicators that holistically present air, water, and land pollutant release data, have been thoroughly reviewed by experts from both inside and outside the EPA. What will you find in this Notebook? The Notebook ...
-
Technology strategy revealed: patterns and influences of patent-licensing behaviour in Japanese firms
Patterns of patent in-licensing and out-licensing are examined among Japanese firms in the pharmaceuticals and electronics industries. Sixty-five questionnaires and 24 interview-based cases provide insights into what influences the decisions to "make-or-buy" (in-license) knowledge assets and to "exploit-or-sell" (out-license) R&D outputs. Firm size and resources, the existing portfolio of ...
-
Managing B2B relationships in the Croatian pharmaceutical industry
The main purpose of CRM is to get to know the customer as well as possible, which can help a company to deliver better, more appropriate and higher added value to the customer. A strong connection with the customers is the key to their satisfaction, especially if this connection is attained through recognising the customers' needs. This can become one of the crucial competitive advantages. Those ...
-
The effects of globalisation on the pharmaceutical industry in emerging markets: the case of Turkey
Foreign Direct Investment (FDI) has become the most important determinant in the process of globalisation, and as such, it is changing the economies of many countries. The main objective of this research is to investigate the nature of FDI inflows into the Turkish pharmaceutical industry and examine whether local or multinational firms drive the changing market. The paper indicates that when ...
-
The choice of technology intelligence methods in multinationals: towards a contingency approach
The effectiveness of technology management is fundamentally influenced by the quality of a firm's technology intelligence process, i.e. the acquisition and assessment of information on technological trends. Although there is a vast literature on different technology intelligence methods, there is a lack of research on the factors influencing the choice of appropriate technology intelligence ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you